date:Dec 20, 2012
venture of AAK and Enzymotec. The double-blind, randomized study conducted at the Neonatology departments of Bnai Zion Medical Center and Meir Medical Center in Israel investigated the effect of InFat on the intestinal flora of term infants.
The clinical trial included 36 term infants, 14 breast-fed and 22 formula-fed who were randomly assigned to receive either formula with InFat (high beta-palmitate) or a control formula (standard vegetable oil mix) that did not contain any pre- or probiotic